2020
DOI: 10.1002/14651858.cd000515.pub5
|View full text |Cite
|
Sign up to set email alerts
|

Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
75
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 82 publications
(79 citation statements)
references
References 96 publications
1
75
0
3
Order By: Relevance
“…A Cochrane analysis comparing CEA to CAS was able to assess 30-day periprocedural risk of death and stroke by acquiring individual patient data from five trials. 10 Sex-specific assessments of long-term outcomes were largely limited to 5-year risk of stroke (ipsilateral or any)±death. 4 5 9 Sex-specific differences relating to the degree of stenosis were only reported in studies comparing CEA to BMT.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A Cochrane analysis comparing CEA to CAS was able to assess 30-day periprocedural risk of death and stroke by acquiring individual patient data from five trials. 10 Sex-specific assessments of long-term outcomes were largely limited to 5-year risk of stroke (ipsilateral or any)±death. 4 5 9 Sex-specific differences relating to the degree of stenosis were only reported in studies comparing CEA to BMT.…”
Section: Resultsmentioning
confidence: 99%
“…4 Comparing CEA to CAS at 30 days, there was a nonsignificant trend towards an increased hazard with CAS. 10 No study compared CAS to BMT. Adverse events were not reported by sex.…”
Section: Resultsmentioning
confidence: 99%
“…Approximately 6.5 million strokes occur per year. [1] Stroke is the second leading cause of death and is the leading cause of premature mortality and morbidity for both men and women. [2,3] Atherosclerotic carotid artery stenosis (CS) is responsible for ~20% of strokes.…”
Section: Introductionmentioning
confidence: 99%
“…Concern regarding the risk of distal embolization of debris being dislodged from the atheromatous plaque during stent deployment and resulting in neurological deficit has led to the introduction and increasing use of cerebral embolic protection devices (EPD), but evidence on protection devices used during CAS is scarce since a small amount of randomized evidence comparing the different cerebral protection systems exists. [1] However, ESVS guidelines' class of recommendation for the use of EPDs in patients undergoing CAS is defined as class IIa. [8] The local anatomic and lesion factors increase the fluoroscopy time and risks associated with CAS [19] whereas systemic factors and comorbidities increase the risks associated with CEA.…”
Section: Introductionmentioning
confidence: 99%
“…The rationale behind treating carotid stenosis in the first place is the same behind treating carotid before coronary stenosis when concomitant [ 6 ]: a decrease in cardiac output may worsen ischemia downstream a carotid stenosis. Although carotid endarterectomy is considered in general safer and more effective than CAS [ 7 ], this is doubtful when concomitant NAVF is present, as NAVF has been an exclusion criteria in trials addressing safety and efficacy of carotid endarterectomy [ 8 ]. In these patients, CAS was preferred because it does not oblige to stop anticoagulation [ 9 ] and it is used in combination with a device that can stop cardiac emboli generated by reflex alteration of the cardiac rhythm by carotid baroreceptors.…”
mentioning
confidence: 99%